LiveDrop
Develops advanced microfluidic instruments for high-throughput biological screening and droplet-based research.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
* | €1.0m | Seed | |
| Total Funding | 000k | ||
| EUR | 2022 | 2023 |
|---|---|---|
| Revenues | 0000 | 0000 |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
LiveDrop is a cutting-edge droplet microfluidic device designed for high-throughput encapsulation of biological materials, ranging from single cells to complex spheroids. The system features zero dead volume, enabling the processing of 100% of the injected sample, which is particularly advantageous when working with rare or limited biological materials. LiveDrop offers a highly flexible platform capable of supporting a wide variety of assays and workflows, making it suitable for diverse applications in biological research and diagnostics. The device also provides a full spectrum for multiplex fluorescence screening, allowing comprehensive and simultaneous analysis of multiple targets within a single experiment.
Keywords: droplet microfluidics, high-throughput encapsulation, single cells, spheroids, zero dead volume, rare materials, flexible platform, biological assays, multiplex fluorescence screening, sample processing, biotechnology